Key points are not available for this paper at this time.
As surgical procedures transition from conventional resection to advanced tissue-regeneration technologies, human disease therapy has witnessed a great leap forward. In particular, three-dimensional (3D) bioprinting stands as a landmark in this setting, by promising the precise integration of biomaterials, cells, and bioactive molecules, thus opening up a novel avenue for tissue/organ regeneration. Curated by the editorial board of Bio-Design and Manufacturing, this review brings together a cohort of leading young scientists in China to dissect the core functionalities and evolutionary trajectory of 3D bioprinting, by elucidating the intricate challenges encountered in the manufacturing of transplantable organs. We further delve into the translational pathway from scientific research to clinical application, emphasizing the imperativeness of establishing a regulatory framework and rigorously enforcing quality-control measures. Finally, this review outlines the strategic landscape and innovative achievements of China in this field and provides a comprehensive roadmap for researchers worldwide to propel this field collectively to even greater heights.
He et al. (Sat,) studied this question.